Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effects of two weeks of recombinant growth hormone administration on the response of IGF-I and N-terminal pro-peptide of collagen type III (P-III-NP) during a single bout of high resistance exercise in resistance trained young men.
Velloso CP, Aperghis M, Godfrey R, Blazevich AJ, Bartlett C, Cowan D, Holt RI, Bouloux P, Harridge SD, Goldspink G. Velloso CP, et al. Among authors: goldspink g. Growth Horm IGF Res. 2013 Jun;23(3):76-80. doi: 10.1016/j.ghir.2013.01.002. Epub 2013 Feb 19. Growth Horm IGF Res. 2013. PMID: 23433656 Clinical Trial.
Age-related loss of muscle mass and strength.
Goldspink G. Goldspink G. J Aging Res. 2012;2012:158279. doi: 10.1155/2012/158279. Epub 2012 Mar 8. J Aging Res. 2012. PMID: 22506111 Free PMC article.
Growth factors, muscle function, and doping.
Goldspink G, Wessner B, Tschan H, Bachl N. Goldspink G, et al. Endocrinol Metab Clin North Am. 2010 Mar;39(1):169-81, xi. doi: 10.1016/j.ecl.2009.11.001. Endocrinol Metab Clin North Am. 2010. PMID: 20122457
High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration.
Kay RG, Barton C, Velloso CP, Brown PR, Bartlett C, Blazevich AJ, Godfrey RJ, Goldspink G, Rees R, Ball GR, Cowan DA, Harridge SD, Roberts J, Teale P, Creaser CS. Kay RG, et al. Among authors: goldspink g. Rapid Commun Mass Spectrom. 2009 Oct;23(19):3173-82. doi: 10.1002/rcm.4237. Rapid Commun Mass Spectrom. 2009. PMID: 19718777 Clinical Trial.
A proteomic approach combining MS and bioinformatic analysis for the detection and identification of biomarkers of administration of exogenous human growth hormone in humans.
Boateng J, Kay R, Lancashire L, Brown P, Velloso C, Bouloux P, Teale P, Roberts J, Rees R, Ball G, Harridge S, Goldspink G, Creaser C. Boateng J, et al. Among authors: goldspink g. Proteomics Clin Appl. 2009 Aug;3(8):912-22. doi: 10.1002/prca.200800190. Epub 2009 Jul 30. Proteomics Clin Appl. 2009. PMID: 21136995
210 results